Potrero Medical Receives FDA Breakthrough Device Designation for Accuryn AKI Predict Algorithm
HAYWARD, Calif., Sept. 13, 2022 /PRNewswire/ — Potrero Medical announced today that the FDA granted Breakthrough Device Designation for their AKI Predict machine learning algorithm, for the advanced prediction of acute kidney injury (AKI) associated with intra-abdominal hypertension…
Comments Off on Potrero Medical Receives FDA Breakthrough Device Designation for Accuryn AKI Predict Algorithm